Table V.
Compound | tR1 | tR2 | α | RS | Flow rate (mL min−1) |
---|---|---|---|---|---|
Doxylamine | 14.942 | 15.699 | 1.09 | 1.92 | 0.4 |
9.972 | 10.482 | 1.09 | 1.88 | 0.6 | |
7.465 | 7.840 | 1.09 | 1.85 | 0.8 | |
5.962 | 6.260 | 1.09 | 1.79 | 1.0 | |
4.985 | 5.238 | 1.09 | 1.76 | 1.2 | |
Cetirizine | 17.157 | 20.268 | 1.29 | 4.46 | 0.4 |
11.574 | 13.701 | 1.29 | 4.07 | 0.6 | |
8.625 | 10.208 | 1.29 | 3.74 | 0.8 | |
6.876 | 6.137 | 1.28 | 3.39 | 1.0 | |
5.759 | 6.819 | 1.29 | 3.23 | 1.2 | |
Hydroxyzine | 31.543 | 33.714 | 1.09 | 1.91 | 0.4 |
21.566 | 23.091 | 1.09 | 1.83 | 0.6 | |
16.382 | 17.549 | 1.09 | 1.74 | 0.8 | |
13.042 | 13.966 | 1.09 | 1.66 | 1.0 | |
10.952 | 11.739 | 1.09 | 1.59 | 1.2 |
Chromatographic conditions. Doxylamine: mobile phase was n-hexane–ethanol (90/10, v/v, 0.1% DEA); cetirizine: mobile phase was n-hexane–isopropanol (60/40, v/v, 0.1% DEA); hydroxyzine: mobile phase was n-hexane–isopropanol (90/10, v/v, 0.1% DEA). The column temperature was at 25°C.